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Objective: To explore the risk of adverse maternal and perinatal outcomes in women with antepartum bleeding of unknown origin (ABUO).
Design: Cohort study based on data extracted from the Aberdeen Maternity and Neonatal Databank. Exposure was antepartum haemorrhage occurring after the first trimester not attributable to placenta praevia or abruption.
Setting: Aberdeen Maternity Hospital, Aberdeen, Scotland. 
Population: All primigravidae delivering between 1976 and 2010.
Methods: Data were analysed using univariate and multivariate statistical methods.
Main outcome measures: Preeclampsia, induced labour, mode of delivery, preterm delivery, postpartum haemorrhage, admission to neonatal unit, perinatal death.
Results: Between 1976 and 2010, there were 7,517 women with ABUO and 68,423 women without. Women with ABUO were more likely to be non-smokers, belong to lower social class and have higher body mass index. ABUO was a significant risk factor for induced labour (adj. OR 1.23, 95% CI 1.16, 1.31), preterm delivery < 37 weeks (adj. OR 2.30, 95% CI 2.11, 2.50) and postpartum haemorrhage (adj. OR 1.15, 95% CI 1.06, 1.25). There was no significant association detected with preeclampsia (adj. OR 0.93, 95% CI 0.83, 1.05). While there was an increased risk of low birth weight (adj. OR 0.90, 95% CI 0.79, 1.03) and stillbirth (adj. OR 0.92, 95% CI 0.66, 1.30) with ABUO on univariate analysis, once adjusted for confounders this risk was non-significant. 
Conclusion: Pregnancies complicated by ABUO are at a greater risk of preterm delivery and induced labour.  There was no increase seen in perinatal mortality after adjusting for preterm birth.






Several publications have previously established adverse pregnancy outcomes associated with placenta praevia or placental abruption. Where antepartum haemorrhage (APH) is not attributable to either of these serious conditions, literature is sparse and sometimes conflicting regarding the associated risk of adverse perinatal outcomes and management of these cases. Yet, the condition of antepartum bleeding of unknown origin (ABUO) is by far the commonest form of APH contributing to 50% of all APH and may complicate upto 6% of pregnancies1. Diagnosis is by exclusion of placental causes using ultrasonic examination2,3 . In the absence of clear guidelines, ABUO is often managed as cases of mild acute placental separation4.
In their review, Magann et al5 found consistent associations between ABUO and preterm delivery, stillbirth and congenital anomalies. There was considerable heterogeneity in the definitions of exposure and outcomes in the ten studies included in the review. Many of the studies did not report the magnitude of association for crude or adjusted analysis. An updated search in Medline identified five additional papers assessing other adverse perinatal outcomes associated with ABUO6-10, but considerable uncertainty remained with regard to associations with pre-eclampsia and eclampsia, induction of labour, operative delivery, preterm pre-labour rupture of membranes (PPROM), and malpresentation and malposition. Magann5 called for larger prospective studies with ability to correct for confounding factors such as maternal age, parity, gestational age and comorbidities.
Given the conflicting evidence surrounding the risks associated with ABUO and the uncertainity regarding its management, we aimed to assess the risks of adverse pregnancy outcomes associated with ABUO using our population based database of routinely collected obstetric data. Although essentially retrospective in nature, we felt the analysis of  this large database would add to the available evidence and perhaps provide directions for future research. 
Material and methods:
Data source: The Aberdeen Maternity and Neonatal Databank was established in 1950 and since then has been continuously recording pregnancy related events occurring in women resident in Aberdeen city and district in the northeast of Scotland. Complications related to pregnancy and delivery as well as comorbidities are coded using ICD-9 and 10 criteria. Details of the background and structure of the databank are available from the website – www.abdn.ac.uk/amnd (​http:​/​​/​www.abdn.ac.uk​/​amnd​)11. Data were extracted from this database using predetermined criteria.
Study population: The study population was limited to all primigravid women in order to minimise the confounding effect of parity. We included all women who delivered singleton babies after 24 completed weeks of gestation between 1976 and 2010 in Aberdeen Maternity Hospital.

Study design: A cohort study design was used where the exposed cohort comprised of women with ABUO while those women without any antepartum haemorrhage comprised the unexposed cohort. The outcomes assessed were classified into two groups – maternal and perinatal. Maternal outcomes included gestational hypertension, preeclampsia/eclampsia, preterm prelabour rupture of membranes (PPROM), induction of labour, mode of delivery, and postpartum haemorrhage (PPH). Perinatal outcomes included preterm birth (delivery before 37 weeks of gestation), low birth weight (birthweight less than 2500g), stillbirth, neonatal death, malposition or presentation, and admission to neonatal intensive care.
Statistical analysis: Univariate analysis was conducted to identify one-to-one relationships between each maternal or perinatal outcomes and ABUO without adjusting for confounders. Here, crude odds ratio was identified as a measure of association. Binary logistic regression was used to identify the relationship between the explanatory variable ABUO and each dichotomous outcome variable. Similarly, multinomial logistic regression was performed when the outcome variable had more than two categories.
Multivariate logistic regression analysis was carried out to identify the relationship between each maternal or perinatal outcome and ABUO by adjusting for confounding variables. The socio-demographic variables which showed significant association at the 5% level of significance with ABUO on univariate analysis were included in the model to obtain adjusted odds ratios with 95% confidence intervals. 
Permission to carry out the study was granted by the steering committee of the Aberdeen Maternity and Neonatal Databank. As only anonymised, routinely-collected data were used in the analysis, formal ethical approval was not considered necessary by the North of Scotland Research Ethics Service.
Results:
At first, the dataset with a total sample size of 77,169 primigravid women was obtained from the AMND. Data cleaning began by filtering out 650 cases of placenta praevia and abruptio placentae, leaving 76,519 cases in the dataset. Women with missing or out of range values in the outcome variables were excluded from the analysis. Statistical analysis was carried out on 75,940 primigravid women. Figure 1 shows the flow diagram of study population selection.
ABUO as a complication after the first trimester of pregnancy occurred in 9.89% (n = 7517) of pregnancies. Table 1 presents the socio-demographic characteristics of women with and without ABUO. The mean age (SD) was 25.70 (5.66) years for women with ABUO and 25.78 (5.29) years for women without APH. This difference was not statistically significant. Thirty nine per cent of women with ABUO belonged to a manual social class (according to the registrar general’s occupation based social class) as did 38.1% of women with no APH. Women with ABUO were more likely to be non-smokers or ex-smokers compared to women without APH. A significantly higher proportion of women were single (20.7% vs 17.6%; P <0.001) among women with ABUO. There was a statistically significant difference between the median [interquartile range (IQR)] BMI of women 23.44 (21.38, 26.45) in the ABUO group and 23.75 (21.61, 26.67) in the no APH group. Social class, smoking, marital status and BMI were found to be significantly associated with ABUO.
Table 2 represents the univariate and multivariate comparison of maternal outcomes between the exposed and unexposed cohorts. The proportion of women with gestational hypertension (19.8% vs 21.9%), pre-eclampsia and eclampsia (5.9% vs 6.9%), and other hypertension (0.7% vs 0.9%) were significantly less for women with ABUO compared with those without APH. However, multivariate analysis showed that the association with gestational hypertension (adj. OR 0.98; 95%CI 0.91, 1.05), pre-eclampsia and eclampsia (adj. OR 0.93; 95%CI 0.83, 1.05), and other hypertension (adj. OR 0.92; 95%CI 0.69, 1.25) was no longer statistically significant after adjusting for confounders. The proportion of women with PPROM was equal in both groups (0.8%).
The proportion of women having induced labour in the ABUO group was 38.2% and 35% among women with no APH (P <0.001). After adjusting for confounders, the risk of induced labour remained statistically significant (adj. OR= 1.23; 95% CI 1.16, 1.31).
Out of the total women with ABUO, 12.3% had PPH, which was slightly higher than among women in the no APH group (10.2%). The odds of PPH were higher {1.15 (95% CI 1.06, 1.25)} in women with ABUO compared to women without APH, after adjusting for confounders.
Caesarean delivery (CS) was slightly higher (20.2%) in the ABUO group than in the no APH group (18.5%) (P <0.001); however, after adjusting for confounders, this difference was no longer significant.  
Table 3 shows the results regarding the relationship between perinatal outcomes and ABUO. The proportion of preterm delivery was 14.1% among women with non-specific APH and 6.4% among women without APH. Even after adjusting for confounders, an elevated risk of preterm delivery (adj. OR 2.30; 95% CI 2.11, 2.50) remained associated with ABUO.
The proportion of stillbirths was 1.3% among women with ABUO and 0.6% in the no APH group. There was 2.17 (95% CI = 1.74, 2.71) times increased odds of stillbirth among women with ABUO compared with women without APH on univariate analysis.  However, there was no independent association seen between ABUO and stillbirth after adjusting for other confounders, notably preterm birth in the multivariate analysis{AOR 0.92 (95% CI 0.66, 1.30)}. Similarly, the proportion of neonatal deaths was 0.7% in the ABUO group and 0.4% in the no APH group. There was 1.60 (95% CI 1.18, 2.16) times increased odds of neonatal death in women with ABUO than women without APH (P = 0.04) seen on unadjusted analysis; but this association was no longer statistically significant after adjusting for confounding factors in the multivariate model {AOR 0.92 (95% CI 0.61, 1.38)}.
The proportion of low birth weight (LBW) among women with ABUO (12.4%) was almost twice that for women without APH (6.6%). LBW was significantly associated with ABUO with a two-fold elevated risk  (2.00; 95%CI 1.86, 2.16) in the unadjusted analysis; however, the adjusted OR {0.90(95% CI 0.79, 1.03)}for LBW was statistically non-significant.
The proportion of admissions to neonatal care unit (NICU) was significantly higher among the group of women with ABUO than in women with no APH, but no significant association (adj OR=1.03; 95% CI = 0.94, 1.12) between ABUO and neonatal admission to intensive care was found after multivariate analysis. 
Discussion:
Principal findings: The results of this study indicate that non-specific bleeding after the first trimester complicates 9.89% of pregnancies. ABUO was linked to some adverse outcomes. ABUO was significantly associated with induced labour, PPH, whereas no association with hypertensive disorders of pregnancy, PPROM and elective or emergency CS was seen. ABUO also appears to be strongly associated with preterm delivery. However, other adverse perinatal outcomes such as stillbirth, neonatal death, low birth weight, and admission of baby to the NICU appear to have no association with ABUO after adjusting for confounding factors.
Strengths and limitations: To our knowledge, this is the largest epidemiological study exploring the association between ABUO and maternal and perinatal complications. The AMND offers a unique opportunity to study the effects of ABUO using routinely collected population based data at minimal cost. Contemporaneous data entry, using consistent coding criteria and various quality assurance checks make the data valid and reliable and also minimizes recall bias12. The study was carried out on data which dates back to 1976. Year of delivery was adjusted in the analysis to control for any changes in the definition of exposure and other outcome variables, as well as in clinical practice over such a long period of time. The effect of parity on maternal and perinatal outcomes was prevented by restricting the study to primigravid women because the risk of adverse pregnancy outcomes varies according to parity. The ability to account for a large number of covariates is also a strength of this analysis.
As the study consisted of a very large sample it is possible that the differences detected between exposed and non-exposed groups may be due to chance alone. Women experiencing light bleeding during the antepartum period may not seek hospital consultation, which may lead to those cases being missed thereby resulting in selection bias. There is no differentiation made in the AMND between single or recurrent episodes of ABUO, the amount of bleeding, or for the gestation at which the ABUO occurred as long as it occurred after the first trimester.  We also acknowledge that some minor cases of placental separation may have been misclassified as ABUO. As the study is based on secondary data, the presence of missing values and retrospective nature of data collection may have biased the results to some extent. As the study was restricted to primigravid women, its results may not be generalizable to multigravid women or women with restricted healthcare access.
Comparison with literature: As per the results of this study, the prevalence of ABUO was 9.89%, which was higher than other reports - 5%10 and 1–2% 5-7. This may be because the AMND collects data from Aberdeen Maternity Hospital which is a tertiary maternity care hospital where complicated pregnancies are overrepresented. Moreover, the current study was restricted to nulliparous women, where the prevalence of APH is known to be higher.
Although the absolute risk of pre-eclampsia and eclampsia was found to be lower in women with ABUO, the association was not statistically significant on multivariate analysis. Pre-eclampsia is a condition that typically develops in late pregnancy. It is possible that the increased rates of preterm delivery associated with ABUO may have contributed to the slight reduction in risk of pre-eclampsia seen in this study. The increased rates of preterm delivery may also explain the non-significant association of ABUO with stillbirth found on multivariate analysis. Incidentally, McCormack et al.10 and Harlev et al.8 also found a significantly lower risk of pre-eclampsia and eclampsia in women with ABUO. On the other hand, Koifman et al9 reported an increased risk of preeclampsia in these women.
Induction of labour appeared to be significantly increased in both univariate and multivariate analyses. This was supported by the results of McCormack et al.10, who showed an elevated risk of induction at term among women with ABUO. While it is difficult to be certain that the reason for induction of labour was mainly the ABUO, adjusting for confounders should have addressed this.  Episodes of ABUO, especially if significant or recurrent may result in anxiety in both the woman and the health care professional, and may explain the increased induction rate.  However, a significantly lower risk of induction of labour was found by Koifman et al9.  
We also found that women with ABUO had an increased risk of PPH in both univariate and multivariate analyses, showing a highly significant association between them. This was supported by Harlev et al8, who showed a significant increase in the risk of PPH among women with idiopathic vaginal bleeding on crude analysis. None of the published studies assessed the adjusted risk of PPH.
A strong and consistent association has been reported between ABUO and preterm delivery5-10. Similarly, the results of studies conducted by Berkowitz et al13, Signore et al14 and Sipila et al.15  were also in agreement with the results of this study, which showed that women with ABUO were more than twice as likely to have preterm delivery. Applying Hill’s criteria of causality, we can therefore say that at least in the case of preterm delivery, the association is likely to be causal. We cannot definitely infer causality from the other associations detected in this study as the literature is conflicting and the likelihood of type 1 error is possible.
Clinical Implications: While the strong association with preterm delivery may be at least partially related to the lowered threshold to intervene in cases of ABUO16, the increased risk of preterm delivery remained even after adjusting for induction of labour, indicating susceptibility to spontaneous preterm delivery in women with ABUO.  ABUO then might be a risk marker for preterm delivery allowing vigilance on the part of clinicians, and to prepare for appropriate care in advance, such as administration of corticosteroids. The risk of stillbirth and hypertensive disorders was not different in women with and without ABUO; but it is interesting to speculate how fetal wellbeing would be affected had labour not been induced early or occurred spontaneously, as there is an inverse relationship between preterm delivery and late stillbirths.18 It is impossible to make any recommendations regarding early delivery of ABUO pregnancies based on retrospective data, but this analysis perhaps paves the way for a randomized controlled trial comparing expectant management with appropriate monitoring versus early delivery for cases of ABUO.  
Conclusion: Pregnancies complicated by ABUO are at greater risk of preterm delivery; the risks of stillbirth and neonatal mortality appear not be to be increased with ABUO once preterm births are taken into account.
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Table 1 Comparison of baseline characteristics between ABUO and no APH
Characteristics	ABUO(n = 7,517)	No APH(n = 68,423)	P value
	No	%	No	%	
Age at delivery	25.70 (5.66)*	25.78 (5.29)*	0.22
Social classNon-manualManualMissing	223829732306	29.839.630.7	213662609320964	31.238.130.6	0.02
Smoking statusNever smokedCurrent smokerEx-smokerMissing	379120615091156	50.427.46.815.4	3267318539421212999	47.827.16.219.0	<0.001
Marital statusNot singleSingle	59601557	79.320.7	5638312040	82.417.6	<0.001
Body mass index	23.44 (21.38, 26.45)**	23.75 (21.61, 26.67)**	<0.001



















Table 2 Association between ABUO and maternal outcomes@
Characteristics	ABUO(n = 7, 517)	No APH (n = 68,423)	Unadjusted	Adjusted*
	  No	%	No	%	OR (95% CI)	P value	OR (95% CI)	P value
Pre-eclampsia and eclampsiaNoGestational hypertensionPre-eclampsia and eclampsiaOther 	5529149244155	73.619.85.90.7	48,056150114746610	70.221.96.90.9	1.000.86 (0.81, 0.92)0.81 (0.73, 0.89)0.78 (0.59,1.03)	<0.001<0.0010.08	1.000.98 (0.91, 1.05)0.93 (0.83, 1.05)0.92 (0.69, 1.25)	0.530.260.61
PPROMNoYes	745562	99.20.8	67,899524	99.20.8	1.001.08 (0.83, 1.40)	0.58	1.001.43 (1.00, 2.03)	0.05
Induced labourNoYes	46452872	61.838.2	44,46323,960	65.035.0	1.001.15 (1.09,1.20)	<0.001	1.001.23 (1.16, 1.31)¥	<0.001
Type of delivery NormalInstrumentalAssisted breech and breech extractionCaesarean Delivery	38562060861515	51.327.41.120.2	35,45119,54778112,644	51.828.61.118.5	1.000.97 (0.92, 1.02)1.01 (0.81, 1.27)1.10 (1.03, 1.17)	0.270.910.003	1.001.03 (0.97, 1.10)†0.85 (0.64, 1.13)†1.01 (0.94, 1.08)†	0.310.270.78
CS typeNon-caesarean deliveryElectiveEmergency	60022731242	79.83.616.5	55,779244910,195	81.53.614.9	1.001.04 (0.91,1.18)1.13 (1.06,1.21)	0.59<0.001	1.000.77 (0.66,0.90)‡1.06 (0.98, 1.14)‡	0.0010.13
PPHNoYes	6537922	87.012.3	61,1206974	89.310.2	1.001.24 (1.15, 1.33)	<0.001	1.001.15 (1.06, 1.25)§	0.001
* All adjusted ORs were adjusted for year of delivery, place of residence, social class, smoking, marital status and BMI for all outcome variables.
¥ OR for induced labour also adjusted for *+pre-eclampsia and eclampsia.
§ OR for PPH also adjusted for *+type of delivery and induced labour.
† OR for type of delivery also adjusted for *+PPROM and preterm delivery.
@ missing category in the maternal outcomes was omitted in the table.
‡ OR for CS type also adjusted for *+PPROM and preterm delivery.
PPH, postpartum haemorrhage; CS, caesarean section; PPROM, preterm pre-labour rupture of membranes; OR, odds ratio; CI, confidence interval.

Statistically significant odds ratios are shown in bold
Table 3 Association between ABUO and perinatal outcomes@
Characteristics	ABUO(n = 7517)	No APH(n = 68,423)	Unadjusted	Adjusted*
	No	%	No	%	OR (95% CI)	P value	OR (95% CI)	P value
Preterm delivery (<37 weeks) NoYes	64571060	85.914.1	64,0264397	93.66.4	1.002.39 (2.22, 2.57)	<0.001	1.002.30 (2.11, 2.50)¥	<0.001
Stillbirth NoYes	741899	98.71.3	68,005418	99.40.6	1.002.17 (1.74, 2.71)	<0.001	1.000.92 (0.66, 1.30)§	0.65
Neonatal death NoYes	746849	99.30.7	68,143280	99.60.4	1.001.60 (1.18, 2.16)	0.004	1.000.92 (0.61, 1.38)†	0.68
LBW (<2500gm) NoYes	6582935	87.612.4	63,8864537	93.46.6	1.002.00 (1.86, 2.16)	<0.001	1.000.90 (0.79, 1.03)‡	0.13
Baby presentation at delivery Normalabnormal	61841333	82.317.7	56,05412,369	81.918.1	1.000.98 (0.92, 1.04)	0.46	1.000.96 (0.90, 1.03)≡	0.29
Admission to Neonatal Care UnitNoYes	64631054	86.014.0	61,8386585	90.49.6	1.001.53 (1.43, 1.64)	<0.001	1.001.03 (0.94, 1.12)⌂	0.56
* All adj ORs were adjusted for year of delivery, social class, smoking, marital status and BMI for all perinatal outcomes.
¥ OR for preterm delivery also adjusted for *+ induced labour.
§ OR for stillbirth also adjusted for *+gestational age, preeclampsia & eclampsia and type of delivery.
† OR for neonatal death also adjusted for *+ gestational age, preeclampsia& eclampsia and type of delivery.
‡ OR for low birth weight also adjusted for *+ gestational age.
.
= OR for baby presentation at delivery also adjusted for *+ gestational age.
⌂ OR for admission to neonatal care unit also adjusted for *+ gestational age, type of delivery and low birth weight.
@ missing category in the perinatal outcomes was excluded from analysis.
LBW, low birth weight; OR, odds ratio; CI, confidence interval.

Statistically significant odds ratios are shown in bold


